Ceramedix, Inc. logo — Eliminating Organ Failure with Tissue Protection Therapies

Ceramedix, Inc.

Eliminating Organ Failure with Tissue Protection Therapies

Founded 2020 United States New York, United States 6 employees Grant Total: $3.01M Biopharma, Health and Wellness +1

General Information

Company Name Ceramedix, Inc.
Founded Year 2020
Location United States New York, United States +1
Employees 6
Industries Biopharma, Health and Wellness, Pharmaceutical
Funding Stage Grant
Social

Get notified when Ceramedix, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ceramedix, Inc.

Ceramedix, Inc. is a biopharmaceutical startup based in New York City focusing on developing breakthrough tissue protection and repair medicines. Founded in 2020, the company has garnered significant attention and funding from both private investors and government agencies, with its last investment being a $3.01M grant investment from the National Institute of Allergy and Infectious Diseases in August 24, 2023. With a mission to "Eliminate Organ Failure with Tissue Protection Therapies," Ceramedix is led by scientific founders from Memorial Sloan Kettering Cancer Center and a Chief Scientific Officer who have a deep understanding of novel signaling biology driving tissue injury. Their innovative drug candidates have a wide range of potential applications, including addressing disease stresses affecting the vascular endothelium of the eye, lung, kidney, and other organs. As a promising player in the biopharma and pharmaceutical industries, Ceramedix is positioned for significant growth and impact in the field of tissue protection and repair therapies.

Taxonomy: Biopharmaceutical, Tissue protection, Drug development, Endothelial tissue, Organ failure treatment, Scientific research, Clinical expertise, Medicinal signaling biology, New York City, Medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 24 Aug 2023

Ceramedix, Inc. Alternatives & Competitors

Ceramedix, Inc. vs

Cardinal Tissue manufactures high quality tissue products: toilet paper, paper towels, napkins, and...

23 employees
Manufacturing, Supply Chain
Ceramedix, Inc. vs

PCT manufacturers & distributes innovative solutions & product for commercial + research plant tissu...

22 employees
Agriculture, Biotechnology
Ceramedix, Inc. vs

Pioneering breakthroughs in regenerative medicine with advanced cell-based and tissue-engineered sol...

Series C
Biotechnology, Pharmaceutical

FAQ About Ceramedix, Inc.

Eliminating Organ Failure with Tissue Protection Therapies
Ceramedix, Inc. was founded in 2020.
Ceramedix, Inc. is headquartered in New York, United States.
Ceramedix, Inc. operates in the following industries: Biopharma, Health and Wellness, Pharmaceutical.
Ceramedix, Inc. has approximately 6 employees.
Ceramedix, Inc. has completed 1 funding round, raising a total of $3.01M. The latest funding stage is Grant.
Top alternatives and competitors to Ceramedix, Inc. include Cardinal Tissue, LLC, Plant Cell Technology, Inc., Advanced BioHealing, HistoGenetics, VIVEX Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ceramedix, Inc. and Cardinal Tissue, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ceramedix, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy